KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $7.0 billion.

  • Edwards Lifesciences' Treasury Shares rose 1576.1% to $7.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year increase of 1576.1%. This contributed to the annual value of $6.2 billion for FY2024, which is 2324.21% up from last year.
  • Per Edwards Lifesciences' latest filing, its Treasury Shares stood at $77.5 million for Q3 2025, which was up 2015.5% from $69.7 million recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Treasury Shares high stood at $77.5 million for Q3 2025, and its period low was $3.0 million during Q1 2021.
  • Moreover, its 5-year median value for Treasury Shares was $41.2 million (2023), whereas its average is $41.5 million.
  • Per our database at Business Quant, Edwards Lifesciences' Treasury Shares skyrocketed by 7145.93% in 2022 and then skyrocketed by 1436.67% in 2024.
  • Over the past 5 years, Edwards Lifesciences' Treasury Shares (Quarter) stood at $2.4 billion in 2021, then surged by 71.46% to $4.1 billion in 2022, then grew by 21.25% to $5.0 billion in 2023, then grew by 23.24% to $6.2 billion in 2024, then grew by 13.84% to $7.0 billion in 2025.
  • Its Treasury Shares stands at $7.0 billion for Q3 2025, versus $6.5 billion for Q2 2025 and $6.5 billion for Q1 2025.